If you listen to former PLS CEO Ken Brinsden he makes a excellent point with the iron ore industry its a compelling case as remember lithium industry is a nuanced niche market.
On the recent market lithium equity volatility:
“Yeah, absolutely. There’s a lot of ill-informed commentary in lithium markets. And it’s kind of a shame because, in some respects the investing public put faith in especially the big banks, but the truth is, the big banks are not close to the lithium market, really at all. And as a result, a lot of their commentary is just fundamentally flawed.
“Most of it comes from the perspective that they want to shape the market based on historical paradigms in lithium raw materials and that just does not work for a market that’s growing as quickly on the demand side as it is for lithium, and for that matter the difficulties in growing supply.
“If you were shaping your commentary about lithium markets in the 2020s based on the 2000s or even to a certain extent the first half of the 2010s you’re fundamentally misreading the market, it has completely changed.
“And the growth that’s underway means there’s a whole heap of new paradigms that describe the shape of the market and that’s the phase that we’re going through now. They mostly get it wrong on the supply side.
“Analysts want to sort of imply that supply will come easily but nothing could be further from the truth. Lithium raw material supply is really difficult to develop and will be for quite some time because the mines are measured in five to seven to 10-year increments for development, and that’s just not the speed that’s required for the demand side growth that’s going on.”
I intend to reavaluate my position after Core Lithium officially becomes a producer, SP will reflect all Core's hard work as Greg English (chairman) stated previously annual report.
But yeah totally agree its tiring to be honest!!)))
- Forums
- ASX - By Stock
- CXO
- Banter and general comments
Banter and general comments, page-18475
-
-
- There are more pages in this discussion • 20,523 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $256.4M |
Open | High | Low | Value | Volume |
11.5¢ | 12.5¢ | 11.0¢ | $3.037M | 25.36M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 318278 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 2878347 | 41 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 268278 | 0.120 |
40 | 2995146 | 0.115 |
60 | 4820343 | 0.110 |
43 | 4085339 | 0.105 |
85 | 4725746 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 2878347 | 41 |
0.130 | 1714806 | 38 |
0.135 | 1280459 | 21 |
0.140 | 837938 | 9 |
0.145 | 762740 | 16 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online